1. Home
  2. WD vs BLTE Comparison

WD vs BLTE Comparison

Compare WD & BLTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Walker & Dunlop Inc

WD

Walker & Dunlop Inc

HOLD

Current Price

$62.77

Market Cap

2.8B

Sector

Finance

ML Signal

HOLD

Logo Belite Bio Inc

BLTE

Belite Bio Inc

HOLD

Current Price

$142.30

Market Cap

4.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WD
BLTE
Founded
1937
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
4.1B
IPO Year
2010
2022

Fundamental Metrics

Financial Performance
Metric
WD
BLTE
Price
$62.77
$142.30
Analyst Decision
Buy
Strong Buy
Analyst Count
2
6
Target Price
$96.00
$149.00
AVG Volume (30 Days)
273.0K
289.5K
Earning Date
11-06-2025
11-10-2025
Dividend Yield
4.28%
N/A
EPS Growth
20.18
N/A
EPS
3.37
N/A
Revenue
$1,160,070,000.00
N/A
Revenue This Year
$19.30
N/A
Revenue Next Year
$10.04
N/A
P/E Ratio
$18.59
N/A
Revenue Growth
17.65
N/A
52 Week Low
$60.72
$49.00
52 Week High
$108.58
$161.32

Technical Indicators

Market Signals
Indicator
WD
BLTE
Relative Strength Index (RSI) 36.14 58.44
Support Level $61.50 $140.07
Resistance Level $64.62 $161.32
Average True Range (ATR) 1.82 12.21
MACD 0.64 -1.03
Stochastic Oscillator 41.95 56.47

Price Performance

Historical Comparison
WD
BLTE

About WD Walker & Dunlop Inc

Walker & Dunlop Inc is a United States-based commercial real estate finance company. It is principally engaged in originating, selling, and servicing a number of multifamily and other commercial real estate financing products that are sold under the programs of Freddie Mac, Fannie Mae, Ginnie Mae, and the Federal Housing Administration. The company is managed based on three reportable segments: Capital Markets (CM), Servicing & Asset Management (SAM), and Corporate. The company generates a majority of total revenue from gains from mortgage banking activities and servicing fees. It conducts business solely in the United States.

About BLTE Belite Bio Inc

Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.

Share on Social Networks: